The Form 4 filing, an SEC report of insider stock activity, was submitted on November 3, 2026. The reported trades took place from October 30 through November 2, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-30 |
| Date of Latest Transaction | 2026-11-02 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 8,635 |
| Price | $641.72 |
| Total Transaction Value | $5,541,209.74 |
| Insider | |
| Ticker Symbol | MA |
| Company | Mastercard Inc |
| Insider Name | Ling Hai |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 35,750.50 |
| Position Size Change | 19.45% |
| Filing | |
| Filing Date | 2026-11-03 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported with transaction code S. The details also suggest a link to an exercise or conversion. An exercise uses a stock option's right to buy shares. A conversion exchanges another type of security for shares.
What was the average price of the transaction?
The average sale price was $641.72 per share across the two reported transactions.
How did this transaction affect the insider's holdings?
Ling Hai sold 8,635 shares and reported owning 35,750.50 shares afterward. The shares sold made up 19.45% of the shares held before the sales.
What's the total transaction value?
The two sales had a total value of $5,541,209.74. Separate values for each sale are not available.
Are there any special circumstances around this transaction?
Yes. The filing information points to a Rule 10b5-1 plan, which sets trading instructions in advance. The available details do not confirm which sales it covers, when it was set up, or its terms.
The possible link to an exercise or conversion comes from matching share counts. Matching counts alone do not prove that the exact shares acquired were sold. The related acquisition details and footnote text are not available here, so that link cannot be confirmed.
For research purposes only; not investment advice.